Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 10 Colonic Neoplasms 9 Prostatic Neoplasms 8 Colorectal Neoplasms 6 Neoplasms 5 Multiple Myeloma 4 Uterine Cervical Neoplasms 3 Stomach Neoplasms 3 Smoldering Multiple Myeloma 3 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Monoclonal Gammopathy of Undetermined Significance 3 Lung Neoplasms 3 Adenomatous Polyposis Coli 3 Uterine Cervical Dysplasia 2 Radiodermatitis 2 Pain 2 Esophageal Neoplasms 2 Breast Carcinoma In Situ 2 cyclopia sequence 1 Uterine Neoplasms 1 Tuberous Sclerosis 1 Thrombocythemia, Essential 1 Stomatitis 1 Sezary Syndrome 1 Seizures 1 Psychological Well-Being 1 Prostate Cancer Metastatic Castration Resistant 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

AZD 6244 19 trametinib 5 Lovastatin 5 Deoxycholic Acid 4 mirdametinib 3 Lasers, Solid-State 3 pirfenidone 2 fludarabine 2 binimetinib 2 Vincristine 2 Vinblastine 2 Transcranial Direct Current Stimulation 2 Specimen Handling 2 Sirolimus 2 Polidocanol 2 Magnetic Resonance Spectroscopy 2 Magnetic Resonance Imaging 2 Lasers 2 Lamotrigine 2 Inhalation 2 Everolimus 2 Carboplatin 2 Blood Specimen Collection 2 Biopsy 2 Acetylcysteine 2 tipifarnib 1 thymoglobulin 1 talimogene laherparepvec 1 pomalidomide 1 peginterferon alfa-2b 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neurofibromatosis 1 × Curcumin × Clear all

NCT05363267 2026-06-01

NF-1, Nutraceutical Intervention

Masonic Cancer Center, University of Minnesota

Phase 1 Active not recruiting

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡